178 related articles for article (PubMed ID: 23922760)
1. Transcriptomic analysis of insulin-sensitive tissues from anti-diabetic drug treated ZDF rats, a T2DM animal model.
Kim YN; Kim S; Kim IY; Shin JH; Cho S; Yi SS; Kim WK; Kim KS; Lee S; Seong JK
PLoS One; 2013; 8(7):e69624. PubMed ID: 23922760
[TBL] [Abstract][Full Text] [Related]
2. Analysis of gene expression profiles in insulin-sensitive tissues from pre-diabetic and diabetic Zucker diabetic fatty rats.
Suh YH; Kim Y; Bang JH; Choi KS; Lee JW; Kim WH; Oh TJ; An S; Jung MH
J Mol Endocrinol; 2005 Apr; 34(2):299-315. PubMed ID: 15821098
[TBL] [Abstract][Full Text] [Related]
3. v- and t-SNARE protein expression in models of insulin resistance: normalization of glycemia by rosiglitazone treatment corrects overexpression of cellubrevin, vesicle-associated membrane protein-2, and syntaxin 4 in skeletal muscle of Zucker diabetic fatty rats.
Maier VH; Melvin DR; Lister CA; Chapman H; Gould GW; Murphy GJ
Diabetes; 2000 Apr; 49(4):618-25. PubMed ID: 10871200
[TBL] [Abstract][Full Text] [Related]
4. Yunpi Heluo decoction attenuates insulin resistance by regulating liver miR-29a-3p in Zucker diabetic fatty rats.
Mao ZJ; Weng SY; Lin M; Chai KF
J Ethnopharmacol; 2019 Oct; 243():111966. PubMed ID: 31128151
[TBL] [Abstract][Full Text] [Related]
5. Hepatic Transcriptome Analysis Revealing the Molecular Pathogenesis of Type 2 Diabetes Mellitus in Zucker Diabetic Fatty Rats.
Xia C; Zhang X; Cao T; Wang J; Li C; Yue L; Niu K; Shen Y; Ma G; Chen F
Front Endocrinol (Lausanne); 2020; 11():565858. PubMed ID: 33329383
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of orexin gene expression by severe obesity in the rats: studies in Zucker fatty and zucker diabetic fatty rats and effects of rosiglitazone.
Cai XJ; Lister CA; Buckingham RE; Pickavance L; Wilding J; Arch JR; Wilson S; Williams G
Brain Res Mol Brain Res; 2000 Apr; 77(1):131-7. PubMed ID: 10814839
[TBL] [Abstract][Full Text] [Related]
7. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
[TBL] [Abstract][Full Text] [Related]
8. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.
Wargent E; Stocker C; Augstein P; Heinke P; Meyer A; Hoffmann T; Subramanian A; Sennitt MV; Demuth HU; Arch JR; Cawthorne MA
Diabetes Obes Metab; 2005 Mar; 7(2):170-81. PubMed ID: 15715890
[TBL] [Abstract][Full Text] [Related]
9. A nonspecific phosphotyrosine phosphatase inhibitor, bis(maltolato)oxovanadium(IV), improves glucose tolerance and prevents diabetes in Zucker diabetic fatty rats.
Winter CL; Lange JS; Davis MG; Gerwe GS; Downs TR; Peters KG; Kasibhatla B
Exp Biol Med (Maywood); 2005 Mar; 230(3):207-16. PubMed ID: 15734724
[TBL] [Abstract][Full Text] [Related]
10. Cocoa-rich diet ameliorates hepatic insulin resistance by modulating insulin signaling and glucose homeostasis in Zucker diabetic fatty rats.
Cordero-Herrera I; Martín MÁ; Escrivá F; Álvarez C; Goya L; Ramos S
J Nutr Biochem; 2015 Jul; 26(7):704-12. PubMed ID: 25814291
[TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat.
Smith SA; Lister CA; Toseland CD; Buckingham RE
Diabetes Obes Metab; 2000 Dec; 2(6):363-72. PubMed ID: 11225966
[TBL] [Abstract][Full Text] [Related]
12. Energy restriction prevents the development of type 2 diabetes in Zucker diabetic fatty rats: coordinated patterns of gene expression for energy metabolism in insulin-sensitive tissues and pancreatic islets determined by oligonucleotide microarray analysis.
Colombo M; Kruhoeffer M; Gregersen S; Agger A; Jeppesen P; Oerntoft T; Hermansen K
Metabolism; 2006 Jan; 55(1):43-52. PubMed ID: 16324918
[TBL] [Abstract][Full Text] [Related]
13. Antidiabetic treatment restores adiponectin serum levels and APPL1 expression, but does not improve adiponectin-induced vasodilation and endothelial dysfunction in Zucker diabetic fatty rats.
Schmid PM; Resch M; Schach C; Birner C; Riegger GA; Luchner A; Endemann DH
Cardiovasc Diabetol; 2013 Mar; 12():46. PubMed ID: 23497197
[TBL] [Abstract][Full Text] [Related]
14. Effects of type-2 diabetes and troglitazone on the expression patterns of small intestinal sugar transporters and PPAR-gamma in the Zucker diabetic fatty rat.
Corpe C; Sreenan S; Burant C
Digestion; 2001; 63(2):116-23. PubMed ID: 11244250
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker-ZDF rats.
Liu X; Pérusse F; Bukowiecki LJ
Am J Physiol; 1998 May; 274(5):R1212-9. PubMed ID: 9644032
[TBL] [Abstract][Full Text] [Related]
16. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
Wasan KM; Risovic V; Yuen VG; McNeill JH
J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice.
Zhang B; Graziano MP; Doebber TW; Leibowitz MD; White-Carrington S; Szalkowski DM; Hey PJ; Wu M; Cullinan CA; Bailey P; Lollmann B; Frederich R; Flier JS; Strader CD; Smith RG
J Biol Chem; 1996 Apr; 271(16):9455-9. PubMed ID: 8621615
[TBL] [Abstract][Full Text] [Related]
18. Cardiac and skeletal muscle fatty acid transport and transporters and triacylglycerol and fatty acid oxidation in lean and Zucker diabetic fatty rats.
Bonen A; Holloway GP; Tandon NN; Han XX; McFarlan J; Glatz JF; Luiken JJ
Am J Physiol Regul Integr Comp Physiol; 2009 Oct; 297(4):R1202-12. PubMed ID: 19675275
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/reperfusion-induced myocardial injury.
Yue TL; Bao W; Gu JL; Cui J; Tao L; Ma XL; Ohlstein EH; Jucker BM
Diabetes; 2005 Feb; 54(2):554-62. PubMed ID: 15677515
[TBL] [Abstract][Full Text] [Related]
20. Glucose transporter levels in tissues of spontaneously diabetic Zucker fa/fa rat (ZDF/drt) and viable yellow mouse (Avy/a).
Slieker LJ; Sundell KL; Heath WF; Osborne HE; Bue J; Manetta J; Sportsman JR
Diabetes; 1992 Feb; 41(2):187-93. PubMed ID: 1733808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
